Clarus Wealth Advisors Emergent Bio Solutions Inc. Transaction History

Clarus Wealth Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 11, 2019	SELL	$40.6 - $57.2 $85,828 - $120,920	-2,114 Closed	0 $0
Q2 2019 Jul 24, 2019	BUY	$39.92 - $53.86 $19,800 - $26,714	496 Added 30.66%	2,114 $102,000
Q4 2018 Feb 05, 2019	BUY	$55.63 - $73.24 $84,446 - $111,178	1,518 Added 1518.0%	1,618 $96,000
Q4 2018 Jan 08, 2019	BUY	$55.63 - $73.24 $5,563 - $7,323	100 New	100 $7,000
Q4 2018 Jan 07, 2019	SELL	$55.63 - $73.24 $5,563 - $7,323	-100 Closed	0 $0

Q3 2018 Oct 03, 2018	SELL	$52.05 - $66.51 $10,410 - $13,302	-200 Reduced 66.67%	100 $7,000
Q2 2018 Jul 05, 2018	BUY	$48.33 - $55.64 $14,499 - $16,692	300 New	300 $16,000

137

35.6M

78.7K

75.1K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $435M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Clarus Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Clarus Wealth Advisors with notifications on news.